KBR, Inc. to Hold Fourth Quarter 2017 Earnings Conference Call
HOUSTON - (February 9, 2018) - KBR, Inc.
KBR Announces Third Quarter 2019 Financial Results
Strong Growth | 12% revenue growth led by restoration of ES growth of 31%; 2.1x consolidated book-to-bill Enduring Performance | EPS of $0.39, Adjuste
KBR Announces First Quarter 2017 Financial Results
Wire ReleaseRevenues of $1.1 billion, up 11% over prior year Solid earnings; GAAP EPS of $0.26 (with $0.02 impact from legacy legal fees) Adjusted 201
KBR Announces Strong Second Quarter 2015 Earnings
Earnings significantly improved from 2014 driven by strong operating performanceCompany remains on track to deliver strategic plan goals for cost savi
KBR Announces Fourth Quarter and Fiscal 2020 Financial Results; Provides 2021 Guidance
Accelerated Earnings Growth and Value Creation Expected Following Strategic Steps Taken in 20204th Quarter 2020 Highlights Completed strategic acquisi
KBR Announces Second Quarter 2019 Financial Results
Strong Growth | 12% revenue growth underpinned by industry leading organic growth in GS and TS Predictable Performance | EPS of $0.34, Adjusted EPS of
KBR Announces Strong Fourth Quarter and Fiscal 2015 Earnings
Q4 and 2015 earnings significantly improved from 2014 driven by strong operating performanceOn track to deliver strategic plan goals for cost savings
KBR Announces Financial Results for Fourth Quarter and Fiscal 2017; Guidance for Fiscal 2018
Wire Release Q4 and 2017 GAAP EPS of $1.94 and $3.06, respectively Adjusted EPS(1) for Q4 and 2017 of $0.28 and $1.49, respectively Operating cash flo
KBR to Construct Oral Solid Dosage Production Facility for Purdue Pharma Manufacturing LP in Durham NC
Houston, Texas - July 9, 2014 - KBR (NYSE: KBR) announced today that KBR Building Group, a subsidiary within KBR's Services Group, has been awarded a